SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-051877
Filing Date
2019-09-30
Accepted
2019-09-30 06:07:14
Documents
5
Period of Report
2019-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-19168_18k.htm 8-K 37348
2 EX-10.1 a19-19168_1ex10d1.htm EX-10.1 110600
3 EX-10.2 a19-19168_1ex10d2.htm EX-10.2 129427
4 EX-10.3 a19-19168_1ex10d3.htm EX-10.3 108454
5 EX-10.4 a19-19168_1ex10d4.htm EX-10.4 158979
  Complete submission text file 0001104659-19-051877.txt   546043
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 191123956
SIC: 3845 Electromedical & Electrotherapeutic Apparatus